As shown in Fig. 4A,, treatment of A549 and H460 cells with a highly selective PI3K/Akt pathway inhibitor, LY294002 (30 μM), could block the enhancement effect of NOX4 on NSCLC cell growth and invasion. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.